AbbVie Earnings Preview: Immunology portfolio remains in focus amid Humira decline
[AbbVie] hapabapa AbbVie (ABBV [https://seekingalpha.com/symbol/ABBV]) is projected to report a solid second-quarter print, with double-digit growth seen for both top and bottom lines. EPS is expected to go up 67% Y/Y to $3.61 [https://seekingalpha.com/symbol/ABBV/earnings/estimates]. This is the higher end of management’s forecast for the …
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8%